Multiple sclerosis (MS) is a chronic demyelinating inflammatory disease of the central nervous system. It is the most common neurological disease in adults and women. The global multiple sclerosis drugs market is rapidly growing due to factors such as growing prevalence of MS, significant unmet needs, and promising pipeline molecules.
The report titled “Bioinformatics Market- Growth, Future Prospects, and Competitive Analysis, 2025 – 2033” offers strategic insights into the overall bioinformatics market along with the market size and estimates for the duration 2020 to 2033. The said research study covers in-depth analysis of multiple market segments based on types of products & services, applications, and different geographies. Bioinformatics helps to carry out processes such as recovery, storage, processing, management, and analysis of organic information through statistical techniques coupled with modern information and technology base.
The plant stem cell market for nutrition is expected to grow at a CAGR of 7.5% during the forecast period of 2025 to 2033. Cells within a plant's meristem that have not yet undergone differentiation can be referred to as stem cells. The ability of plant stem cells to both maintain themselves and provide a steady supply of precursor cells allows plant stem cells to serve as the origin of plant vitality. Plant stem cells are responsible for the formation of a variety of tissues and organs in plants.
Biotechnology has acquired a prime importance for research & development activities of new healthcare applications as well as biological applications, stem cell applications in vitro fertilization & in vivo fertilization and living tissues & cells. Owing to this, biotechnology has become a centre of all research activities.
The global biotechnology market is anticipated to expand at a CAGR of 15% between 2023 and 2030. Government measures aiming at the modernization of the regulatory environment, improvements in approval processes and reimbursement policies, and standardization of clinical research are driving the market. The expanding influence of personalized medicine and the growing number of orphan drug formulations are creating new opportunities for biotechnology applications, encouraging the emergence of creative biotechnology firms, and enhancing market revenue.
Furthermore, genetically engineered crops and herbicide-tolerant and insect-resistant seeds are gaining popularity and contributing to market expansion. Increasing adoption of tissue culture technology for the production of novel rice variants and disease- and pest-free banana varieties in South Asia and Africa, as well as the use of the technology for the cloning of disease-free and nutrient-rich plant varieties, have propelled agricultural applications for biotechnology. A robust clinical trial pipeline and substantial funding opportunities in tissue engineering and regeneration technologies also drive the industry.
Nanobiotechnology is anticipated to grow at the highest CAGR of 14.8% between 2022 and 2030, due to an increase in nanomedicine approvals and the introduction of advanced technology. For instance, applications of theranostics nanoparticles have gained momentum in order to facilitate quick diagnosis and individualization of therapy choices for several diseases simultaneously. Nanoparticles' low toxicity, smaller size, and chemical adaptability have proven advantageous in overcoming the limitations associated with conventional generic drug administration routes. In addition, tissue engineering and regeneration medicine had a sizable proportion of the market due to government and private expenditures in the field, high healthcare spending, and the existence of numerous mature and emerging competitors in this market.
Acute Market Reports is a market research and strategic consulting company specializing in the biotechnology and healthcare industry. The futuristic research technique offered by Acute Market Reports enables our clients to make timely, well-considered business decisions. We partner with a wide range of industry participants to provide cutting-edge strategic research solutions to our global clients.
